Special notice
Notice of Intent to Sole Source – Therakos Inc.
NOI-CC-25-007707
National Institutes of Health, National Institutes of Health - CC. In-Vitro Diagnostic Substance Manufacturing.
Status
Special notice
Posted August 27, 2025. Scheduled to archive September 10, 2025.
Description
As published on SAM.gov.
This procurement is for THERAKOS® CELLEX® Photopheresis System Procedural Kits. Cellex USA Kits are needed for Extracorporeal Photopheresis (ECP) procedures for Clinical Center patients. These kits are only manufactured and sold by the Cellex equipment manufacturer Therakos. These kits are for very rare photopheresis procedures that are not done regularly. The request for these procedures is based on treatment plans that vary based on the condition of the patient(s) and are communicated to us by the primary care team as needed.
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
August 27, 2025
Special notice
SAM.gov, notice 9fed819f6277470ab829680ae556bd29
Points of contact
- Chris Ryssa Nixryssa.nix@nih.gov
Also open from this buyer
- ASIT.TO 1 year software support from ArgonSoft (Notice of Intent to sole source)PresolicitationNAICS 513210Bethesda, MDNOI-CC-26-000808Closes in 48 daysNov 5